Канал: OMedLive

Melanoma: Immune Related Adverse Effects Pearl

Melanoma: Immune Related Adverse Effects Pearl

Personalizing the Management of Advanced Gastric Cancer: Audience Q&A

Personalizing the Management of Advanced Gastric Cancer: Audience Q&A

Personalizing the Management of Advanced Gastric Cancer

Personalizing the Management of Advanced Gastric Cancer

Preventing and Treating Inhibitors in Patients with Hemophilia: Strategies for Success

Preventing and Treating Inhibitors in Patients with Hemophilia: Strategies for Success

08 05 14 omed youtube final

08 05 14 omed youtube final

Integrating New Therapies into the Treatment of Newly Diagnosed MM: Audience Q&A

Integrating New Therapies into the Treatment of Newly Diagnosed MM: Audience Q&A

$Controversies in the Management of Relapsed/Refractory MM$

Controversies in the Management of Relapsed/Refractory MM

Integrating New Therapies into the Treatment of Newly Diagnosed MM

Integrating New Therapies into the Treatment of Newly Diagnosed MM

The Evolving Role of Immunotherapy in Patients with Advanced Melanoma: Audience Q&A

The Evolving Role of Immunotherapy in Patients with Advanced Melanoma: Audience Q&A

The Evolving Role of Immunotherapy in Patients with Advanced Melanoma

The Evolving Role of Immunotherapy in Patients with Advanced Melanoma

Targeted Therapy in Melanoma: Audience Q&A

Targeted Therapy in Melanoma: Audience Q&A

Targeted Therapy in Melanoma

Targeted Therapy in Melanoma

New and Emerging Directions in the Management of Advanced RCC: Audience Q&A

New and Emerging Directions in the Management of Advanced RCC: Audience Q&A

New and Emerging Directions in the Management of Advanced RCC

New and Emerging Directions in the Management of Advanced RCC

Selecting First-line Therapy for Patients with RCC: Audience Q&A

Selecting First-line Therapy for Patients with RCC: Audience Q&A

Selecting First-line Therapy for Patients with RCC

Selecting First-line Therapy for Patients with RCC

Strategies for Minimizing Toxicities in Patients Undergoing Treatment for RCC

Strategies for Minimizing Toxicities in Patients Undergoing Treatment for RCC

Strategies for Minimizing Toxicities in Patients Undergoing Treatment for RCC: Audience Q&A

Strategies for Minimizing Toxicities in Patients Undergoing Treatment for RCC: Audience Q&A

Advancing Personalized Care for Patients with NSCLC: Tumor Genotyping and Biomarkers: Audience Q&A

Advancing Personalized Care for Patients with NSCLC: Tumor Genotyping and Biomarkers: Audience Q&A

Advancing Personalized Care for Patients with NSCLC: Tumor Genotyping and Biomarkers

Advancing Personalized Care for Patients with NSCLC: Tumor Genotyping and Biomarkers

Advances in Targeted Therapy for NSCLC: Audience Q&A

Advances in Targeted Therapy for NSCLC: Audience Q&A

Advances in Targeted Therapy for NSCLC

Advances in Targeted Therapy for NSCLC

Selecting and Optimizing Treatment Strategies in Patients with Metastatic Colorectal Cancer: Q&A

Selecting and Optimizing Treatment Strategies in Patients with Metastatic Colorectal Cancer: Q&A

Screening for Colorectal Cancer: Audience Q&A

Screening for Colorectal Cancer: Audience Q&A

OMedLive ASCO Video

OMedLive ASCO Video

Selecting and Optimizing Treatment Strategies in Patients with Metastatic Colorectal Cancer

Selecting and Optimizing Treatment Strategies in Patients with Metastatic Colorectal Cancer

Beyond the PSA: Emerging Biomarkers for Prostate Cancer Screening

Beyond the PSA: Emerging Biomarkers for Prostate Cancer Screening

The Challenges of Prostate Cancer Survivorship

The Challenges of Prostate Cancer Survivorship

The Role, Timing and Utility of Hormonal Therapies in Patients with Prostate Cancer

The Role, Timing and Utility of Hormonal Therapies in Patients with Prostate Cancer

Managing the Patient with BPH-LUTS and Erectile Dysfunction

Managing the Patient with BPH-LUTS and Erectile Dysfunction

Improving the Recognition and Management of Breakthrough Cancer Pain

Improving the Recognition and Management of Breakthrough Cancer Pain

Overcoming Barriers to Adherence in Hemophilia Treatment

Overcoming Barriers to Adherence in Hemophilia Treatment

Addressing Comorbidities and Long-Term Complications in Patients with Hemophilia

Addressing Comorbidities and Long-Term Complications in Patients with Hemophilia

Therapeutic Advances in the Management of Hemophilia

Therapeutic Advances in the Management of Hemophilia

$Management of Patient with Relapsed/Refractory Multiple Myeloma$

Management of Patient with Relapsed/Refractory Multiple Myeloma

HNSCC: The Importance of Early Detection and Intervention, Pathogenesis, and Treatment Strategy

HNSCC: The Importance of Early Detection and Intervention, Pathogenesis, and Treatment Strategy

Heterogeneity of NSCLC: Optimizing Therapeutic Strategies in Subpopulations

Heterogeneity of NSCLC: Optimizing Therapeutic Strategies in Subpopulations

Inhibition of Molecular Signaling Pathways, Resistance Mechanisms

Inhibition of Molecular Signaling Pathways, Resistance Mechanisms

Making sense of the NCCN guidelines and other evidence for castrate resistant prostate cancer

Making sense of the NCCN guidelines and other evidence for castrate resistant prostate cancer

What do clinicians struggle with in managing CRPC?

What do clinicians struggle with in managing CRPC?

Individualizing therapy for the prostate cancer patient: a growing set of options

Individualizing therapy for the prostate cancer patient: a growing set of options

Immunotherapy for the treatment of advanced prostate cancer

Immunotherapy for the treatment of advanced prostate cancer

What's new on the horizon in CRPC?

What's new on the horizon in CRPC?